Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bharat Jagannathan

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Pharmaceutical Sciences|February 22, 2021
An Industry Perspective on the Challenges of Using Closed System Transfer Devices with Biologics and Communication Guidance to Healthcare ProfessionalsGanapathy Gopalrathnam, Twinkle R Christian, Bharat Jagannathan, et al.
The AAPS Journal|December 5, 2022
End-to-End Approach to Surfactant Selection, Risk Mitigation, and Control Strategies for Protein-Based TherapeuticsAnnette Medina Morales, Alavattam Sreedhara, Jakob Buecheler, et al.
Process Biochemistry (Barking, London, England)|April 4, 2023
Process development of a SARS-CoV-2 nanoparticle vaccineDiandra Martinez-Cano, Rashmi Ravichandran, Huong Le, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Pharmaceutical Sciences|February 22, 2021
An Industry Perspective on the Challenges of Using Closed System Transfer Devices with Biologics and Communication Guidance to Healthcare ProfessionalsGanapathy Gopalrathnam, Twinkle R Christian, Bharat Jagannathan, et al.
The AAPS Journal|December 5, 2022
End-to-End Approach to Surfactant Selection, Risk Mitigation, and Control Strategies for Protein-Based TherapeuticsAnnette Medina Morales, Alavattam Sreedhara, Jakob Buecheler, et al.
Process Biochemistry (Barking, London, England)|April 4, 2023
Process development of a SARS-CoV-2 nanoparticle vaccineDiandra Martinez-Cano, Rashmi Ravichandran, Huong Le, et al.
Pageof 2